Autoplaque vs Viz HCM
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is a detailed, quantitative assessment of coronary artery plaque and luminal stenoses from CT angiography images. This tool is ideal for clinicians seeking precise measurements and characterization of atherosclerotic disease to inform heart attack risk prediction and guide specific treatment strategies.
View Autoplaque →Choose Viz HCM if…
Choose Viz HCM if your priority is real-time, AI-powered detection of suspected Hypertrophic Cardiomyopathy (HCM) directly from ECGs across your health system. This solution is best suited for organizations aiming to significantly reduce HCM diagnosis time and streamline care coordination through automated alerts and patient routing to appropriate specialists.
View Viz HCM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Viz HCM |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Unknown |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz HCMViz HCM (Tool B) is a cloud-based platform with mobile alerts and seamless integration into existing hospital IT systems like EHR and PACS, suggesting high accessibility and integration into clinical workflows. Autoplaque (Tool A) is workstation-based software, which implies a more localized and potentially less integrated user experience.
Clinical Value
Viz HCMBoth tools are FDA-cleared and provide significant clinical value. Viz HCM (Tool B) offers real-time ECG analysis for Hypertrophic Cardiomyopathy detection and intelligent care coordination, which directly reduces diagnosis time and streamlines workflows for a critical, often underdiagnosed condition. Its extensive real-world evidence and publications further support its impact. Autoplaque (Tool A) provides valuable quantitative analysis of coronary plaques from CT angiography for risk prediction, but Tool B's real-time, workflow-integrated approach for HCM detection and coordination demonstrates a broader immediate clinical impact.
Pricing & Value
Viz HCMViz HCM (Tool B) clearly outlines its subscription-based pricing model and provides information on CMS reimbursement codes and rates, offering transparency and a clear path to financial viability for healthcare systems. Autoplaque (Tool A) has not disclosed its pricing, making it impossible to assess its value proposition or potential return on investment.
Enterprise Readiness
Viz HCMViz HCM (Tool B) is a cloud-based platform designed for integration with hospital IT systems (EHR, PACS), explicitly states HIPAA compliance, and confirms the availability of a Business Associate Agreement (BAA). These features are crucial for enterprise adoption in healthcare. Autoplaque (Tool A) is workstation-based and does not specify HIPAA compliance or BAA availability, posing potential hurdles for large-scale deployment.
Innovation
Viz HCMWhile Autoplaque (Tool A) offers innovative AI-powered quantitative analysis of coronary plaques for risk prediction, Viz HCM (Tool B) extends its innovation beyond detection to include real-time mobile alerts and automated direction of patients to appropriate care specialists. This integration of AI detection with intelligent care coordination represents a more comprehensive and innovative approach to improving patient outcomes and streamlining healthcare delivery.
Support & Docs
Viz HCMViz HCM (Tool B) provides extensive support resources, including a dedicated customer support team with 24/7 urgent phone support, email, a help center, customer resources, user guides, and a 'Viz Academy'. Autoplaque (Tool A) implies the existence of user manuals and general contact with Cedars-Sinai, but lacks the explicit, dedicated product support structure offered by Viz.ai.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Viz HCM |
|---|---|---|
| Name | Autoplaque | Viz HCM |
| Company | Cedars-Sinai Medical Center: AIM | Viz.ai |
| Description | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. |
| Primary Disease/Condition Focus | Coronary plaques and luminal stenoses | Hypertrophic Cardiomyopathy (HCM) |
| Input Data Type | CT angiography images | Electrocardiograms (ECG) |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Viz HCM.